Cross Country Healthcare Q3 revenue $250M, down 21% YoY; net loss $4.8M

CROSS COUNTRY HEALTHCARE INC

2025-Q3 EPS reported -$0.37 revenue$817,532,000

Revenue $250.1M, down 21% YoY and 9% sequentially; gross margin 20.4% flat.
Net loss $4.8M vs $1.2M in Q3 2024; diluted EPS ($0.15) vs ($0.23) prior year.
Adjusted EBITDA $6.5M, down 37% YoY; adjusted EPS $0.03 vs ($0.09) a year ago.
Cash from operations $20.1M, up 169% YoY and 377% sequentially.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.